MA24563A1 - Derives de macrolides substitues en position c-4 - Google Patents

Derives de macrolides substitues en position c-4

Info

Publication number
MA24563A1
MA24563A1 MA25106A MA25106A MA24563A1 MA 24563 A1 MA24563 A1 MA 24563A1 MA 25106 A MA25106 A MA 25106A MA 25106 A MA25106 A MA 25106A MA 24563 A1 MA24563 A1 MA 24563A1
Authority
MA
Morocco
Prior art keywords
derivatives
macrolides
substituted
substituted macrolides
Prior art date
Application number
MA25106A
Other languages
English (en)
Inventor
Anthony Letavic Michael
Kancho Takushi
Alan Glazer Edward
Cheng Hengmiao
Scott Bronk Brian
Vera Yang Bingwei
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA24563A1 publication Critical patent/MA24563A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MA25106A 1997-06-11 1998-06-10 Derives de macrolides substitues en position c-4 MA24563A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4998097P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
MA24563A1 true MA24563A1 (fr) 1998-12-31

Family

ID=21962765

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25106A MA24563A1 (fr) 1997-06-11 1998-06-10 Derives de macrolides substitues en position c-4

Country Status (39)

Country Link
EP (1) EP0988309B1 (fr)
JP (1) JP3262806B2 (fr)
KR (1) KR100369959B1 (fr)
CN (1) CN1145636C (fr)
AP (1) AP1189A (fr)
AR (1) AR013085A1 (fr)
AT (1) ATE310742T1 (fr)
AU (1) AU745006C (fr)
BG (1) BG64357B1 (fr)
BR (1) BR9810097A (fr)
CA (1) CA2293397C (fr)
CO (1) CO4950584A1 (fr)
DE (1) DE69832486T2 (fr)
DZ (1) DZ2515A1 (fr)
EA (1) EA002440B1 (fr)
ES (1) ES2251081T3 (fr)
GT (1) GT199800075A (fr)
HN (1) HN1998000074A (fr)
HR (1) HRP980315A2 (fr)
HU (1) HUP0004076A3 (fr)
ID (1) ID24530A (fr)
IL (1) IL132808A (fr)
IS (1) IS1979B (fr)
MA (1) MA24563A1 (fr)
MY (1) MY133027A (fr)
NO (1) NO315560B1 (fr)
NZ (1) NZ500652A (fr)
OA (1) OA11226A (fr)
PA (1) PA8452001A1 (fr)
PE (1) PE79999A1 (fr)
PL (1) PL337497A1 (fr)
SK (1) SK168299A3 (fr)
TN (1) TNSN98084A1 (fr)
TW (2) TW200418871A (fr)
UA (1) UA70298C2 (fr)
UY (1) UY25041A1 (fr)
WO (1) WO1998056801A1 (fr)
YU (1) YU62999A (fr)
ZA (1) ZA985016B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
ES2281136T3 (es) * 1997-09-10 2007-09-16 Merial Ltd. Uso de 9a-azalidos como agentes antimicrobiales veterinarios.
EP1779853A3 (fr) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides en tant qu'agents anti-microbiens à usage vétérinaire
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
EP1437360A3 (fr) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11-carbamates des macrolides antibactériens
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
TR200101241T2 (tr) 1998-11-03 2001-09-21 Pfizer Products Inc. Yeni makrolit antibiyotikler
CA2411293A1 (fr) * 1999-01-28 2000-07-28 Pfizer Products Inc. Nouveaux azalides et procede de fabrication
DK1206476T3 (da) * 1999-08-24 2006-05-15 Abbott Lab 9a-azalider med antibakteriel virkning
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
BRPI0017013B1 (pt) 2000-01-27 2015-07-14 Zoetis P Llc Composição de antibiótico azalídeo e método para sua obtenção
RU2263117C2 (ru) * 2001-04-27 2005-10-27 Пфайзер Продактс Инк. Способ получения 4"-замещенных производных 9-деоксо-9а-аза-9а-гомоэритромицина а
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
AU2003264917A1 (en) 2002-07-08 2004-01-23 Pliva - Istrazivacki Institut D.O.O. Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
EP1521763A2 (fr) * 2002-07-08 2005-04-13 Pliva - Istrazivacki Institut d.o.o. Substances anti-inflammatoires non steroidiennes, compositions et procedes d'utilisation de celles-ci
RS20050008A (sr) 2002-07-08 2007-06-04 Pliva-Istraživački Institut D.O.O., Nova jedinjenja,kompozicije i metode za lečenje inflamatornih oboljenja i stanja
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
EP1638549A4 (fr) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc Nouveaux agents antibacteriens
WO2005030227A1 (fr) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. Derives 9a-azalide 11-3c-bicycliques
EP1723159B1 (fr) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Composes macrocycliques et leurs procedes de fabrication et d'utilisation
JPWO2009019868A1 (ja) 2007-08-06 2010-10-28 大正製薬株式会社 １０ａ、１２位架橋型１０ａ−アザライド化合物
EP2214484A4 (fr) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc Procédé pour la préparation d'agents antibactériens macrolides
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ，インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
WO2012038372A1 (fr) * 2010-09-20 2012-03-29 Novartis Ag Nouveau procédé de préparation de 9-déoxo-9a-aza-9a-homoérythromycine a modifiée dans le c-4'' du cycle cladinose par un groupe époxyde
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 Ｃ−４”位置換マクロライド誘導体を含有する医薬
JP6437523B2 (ja) 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
CN106998685A (zh) 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
EP3273969A4 (fr) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides à sucres modifiés de type désosamine et utilisations de ceux-ci
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法
TWI830987B (zh) * 2020-03-12 2024-02-01 美商碩騰服務公司 免疫調節脲氮雜內酯

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
DE3475073D1 (en) * 1983-09-06 1988-12-15 Pfizer Azahomoerythromycin b derivatives and intermediates thereof
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (fr) * 1991-04-04 1998-08-04 James V. Heck Derives de 9-desoxo-8a-aza-8a-homoerythromycine a modifies en positions 4"- et 8a
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5412982A (en) * 1994-03-10 1995-05-09 Potts; James K. Windsock support

Also Published As

Publication number Publication date
NZ500652A (en) 2001-10-26
UA70298A (uk) 2004-10-15
CO4950584A1 (es) 2000-09-01
KR100369959B1 (ko) 2003-02-12
CA2293397A1 (fr) 1998-12-17
IS1979B (is) 2005-01-14
EA002440B1 (ru) 2002-04-25
TW200418871A (en) 2004-10-01
IL132808A0 (en) 2001-03-19
JP2000514097A (ja) 2000-10-24
PE79999A1 (es) 1999-08-25
JP3262806B2 (ja) 2002-03-04
EA199901014A1 (ru) 2000-06-26
ZA985016B (en) 1999-12-10
SK168299A3 (en) 2000-09-12
UY25041A1 (es) 2000-09-29
HK1025974A1 (en) 2000-12-01
EP0988309B1 (fr) 2005-11-23
AU745006B2 (en) 2002-03-07
ATE310742T1 (de) 2005-12-15
ES2251081T3 (es) 2006-04-16
DZ2515A1 (fr) 2003-02-01
NO996107L (no) 2000-02-10
CN1145636C (zh) 2004-04-14
AP1189A (en) 2003-07-16
CN1259955A (zh) 2000-07-12
KR20010013633A (ko) 2001-02-26
IL132808A (en) 2004-08-31
AP9801254A0 (en) 1998-06-30
NO315560B1 (no) 2003-09-22
CA2293397C (fr) 2004-08-31
HUP0004076A3 (en) 2003-05-28
MY133027A (en) 2007-10-31
ID24530A (id) 2000-07-20
DE69832486D1 (de) 2005-12-29
YU62999A (sh) 2002-10-18
HN1998000074A (es) 1999-01-08
IS5250A (is) 1999-11-16
GT199800075A (es) 1999-11-30
HRP980315A2 (en) 1999-04-30
AR013085A1 (es) 2000-12-13
PA8452001A1 (es) 2000-05-24
WO1998056801A1 (fr) 1998-12-17
AU745006C (en) 2006-02-23
HUP0004076A2 (hu) 2001-04-28
NO996107D0 (no) 1999-12-10
TWI224106B (en) 2004-11-21
EP0988309A1 (fr) 2000-03-29
AU7228198A (en) 1998-12-30
PL337497A1 (en) 2000-08-28
DE69832486T2 (de) 2006-07-27
BG64357B1 (bg) 2004-11-30
UA70298C2 (uk) 2004-10-15
TNSN98084A1 (fr) 2005-03-15
BG103969A (en) 2000-07-31
BR9810097A (pt) 2000-08-08
OA11226A (en) 2003-07-16

Similar Documents

Publication Publication Date Title
MA24563A1 (fr) Derives de macrolides substitues en position c-4
PT934320E (pt) Derivados de naftiridina
PT891332E (pt) Derivados de 6-fenilpiridil-2-amina
PT1005446E (pt) Derivados de n-aroilfenilalanina
PT930302E (pt) Derivados de benzo-sulfona
PT1090019E (pt) Derivados de adenosina
PT915088E (pt) Derivados de d-prolina
PT1104422E (pt) Derivados de fenilxantina
ATE377018T1 (de) Erythromycinderivate
IS5251A (is) 9-oxím erýþrómýsín afleiður
PT928790E (pt) Derivados de tiazolo
PT1070059E (pt) Derivados de cromanona e tiocromanona
EE200000140A (et) Asendatud kromaani derivaadid
DK1027362T3 (da) 2-halogen-6-O-substituerede ketolidderivater
BR9709065A (pt) Derivados de alquilaminobenzotiazole e-benzoxazol
DE69821009D1 (de) 6,9-verbrückte erythromycin-derivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
EE200000144A (et) Asendatud kromaani derivaadid
EP1167375A4 (fr) Derives d'erythromycine
PT1056716E (pt) Derivados de ciclo-hexanodiolo
LV11898A (lv) Eritromicina atvasinajumi
PT1140890E (pt) Derivados de cromano
PT966437E (pt) Derivados de 5-aroilnaftaleno
PT906279E (pt) Derivados de pirrol
PT1060183E (pt) Derivados de 5'-desoxicitidina